- About Us
-
Our Business
-
- Therapeutic Areas Our portfolio is diverse and based upon - Market Research, Regulatory & IP.
- Licensing Licensing activities are excellent opportunities for companies to expand their portfolio.
- Biosimilar Biosimilar are biologic medicines that are developed to match their reference medicine.
-
- CRAM India has grown to be one of the key nations complying GMP manufacturing norms.
- Medical Devices REVA help our clients to deliver customized, cost-effective medical device value chain.
-
API
-
Dosage form
-
-
Operations
- At Reva, we have requisite infrastructure, with a balanced reach across Regulated, Emerging & Expansion markets. And we are committed to helping create healthier communities worldwide through education, outreach and better access to treatment.
-
Research & Development
-
Manufacturing
-
Quality
- Media
- Contact us
News Letters
2023
Year
- March
J&J Talc Unit Asks Judge To Halt Cancer Lawsuits As It Pursues $8.9 Bln Settlement - February
Farming, Pharmaceutical And Health Pollution Fuelling Rise In Superbugs, UN warns - January
Indian Government Likely To Float Global Tender For HPV Vaccine In April; Merck, Serum Institute May Participate
2022
Year
- December
Healthcare Stocks Surge On Renewed Covid Fears; Dr Lal PathLabs, Cipla Rise Up to 6% - November
Regulators Come Knocking on The Doors of Drug Companies - October
U.S. Supreme Court Rebuffs Novartis, Allows Generic Versions of MS Drug - September
Eisai, Biogen Say Alzheimer's Drug Succeeds In Slowing Cognitive Decline - August
U.S. FDA Green Lights Omicron-Targeted COVID Boosters Ahead of Revaccination - July
WHO Declares Monkeypox Outbreak a Global Health Emergency - June
US Pharmacies Reportedly Set Purchase Limit on Emergency Contraception Pills - May
100 Cases, 12 countries: Symptoms to Vaccine, Here’s All You Need to Know About Monkeypox Virus - April
Geopolitical Challenges Across The World Cast a Shadow of Uncertainty: Cipla CEO - March
Antibodies In Children Last At Least 6 Months After COVID; SK Bioscience Vaccine Shows Promise Vs Omicron - February
Molnupiravir Safe For Non-Pregnant, Unvaccinated People: Study - January
Israel Handling Of Omicron Being Watched Worldwide, It Hits Record Cases
2021
Year
- December
Data Shows MRNA Vaccines the Best Boosters Against Covid, Indian Government Must Get Them to India: Dr Gagandeep Kang - November
Biden Told it Will Take Two Weeks to Have Definitive Data On Omicron Variant - October
U.S. Surgeons Successfully Test Pig Kidney Transplant In Human Patient - September
Six Feet Distance May Not Be Enough To Prevent Virus Spread Indoors: Study - August
A Silent Epidemic Brews, During the Pandemic - July
Long Covid' Is Real, A Matter of Deep Concern: WHO Warning - June
U.S. Directs Millions of COVID-19 Shots to Latin America, Africa, Asia - May
Up To 300% More Antibodies When Second Dose Delayed, Says Study - April
Ayear After Covid, Call For ‘One Health’ Approach - March
After Canada, Germany Halts AstraZeneca Jabs For Under-60s Over Clot Risk - February
Chinese Vaccines Sweep Much of the World, Despite Concerns - January
Covid-19: No Herd Immunity In 2021, WHO Warns
2020
Year
- December
Domestic Vaccines Boost Chinese Society’s Confidence in Local Pharma - November
Vaccines: 200 years of progress and scepticism - October
Govt Identifying 30 Crore Priority Beneficiaries for Covid Vaccine, St - September
Covid-19 Vaccination 'Mother of Planning Exercises', Data Should be... - August
Covaxin, India’s 1st Coronavirus Vaccine, May be Available by End... - July
FDA Chief Refuses To Back Trump's Vaccine Prediction - June
Bangladesh Pharma Giant To Sell First Generic Version of Remdesivir... - May
Chinese Scientists Believe New Drug Can Stop Covid-19 'Without... - April
COVID-19 Pandemic Leaves the Private Healthcare Sector in Financial Di - March
India, US Collaborating in Diagnostics to Fight Covid-19: Ambassador - February
Coronavirus Impact: India's Dependence on Chinese APIs May Lead to... - January
Mission 2020, A Revised Agenda for Indian Pharma
2019
Year
- December
Biosimilars in 2020: All Eyes on How Indian Pharmas Cash In... - November
India’s Increased Dependence on Chinese APIs Causing Concern - October
Cancer Research With Homeopathy Reveal Killing Cancer Cells in Lab... - September
Heart-burn for Pharma Firms: After Valsartan, FDA Red-flags... - August
Cancer Burden Rises to 18.1 Million New Cases and 9.6 Million Cance... - July
Japanese Firms Have Generally Cracked the Code of Working in India's H - June
'Gilead's Key Drug Used In HIV-Related Infection Out Of Reach In Developing Countries' - May
Congressman, Industry and Doctors Favour Accelerated Traction on India - April
Indian Pharmaceutical Industry Scores on Compliance with USFDA
2018
Year
- December
Drug Firms Expect Pricing Pressure to Stabilise in US - November
USFDA Drug Approvals at All-time High; Indian Firms Get 35-40% of Nods - March
Drug Makers Want Greater Emphasis on IP Protection in India - February
India launches - world's biggest healthcare program - January
Indian Market Pundits predict a Happy New Year for Bulls